Peptide

Semax + Selank

Synthetic neuropeptides associated with cognition and stress research.

AvailabilityClinical & regulatory review required

A consultation does not guarantee that a product can be supplied.

Background

What it is, how it developed and why it is discussed

Semax and Selank are synthetic peptides developed from neuropeptide research and used or studied in some countries for neurological or anxiety-related contexts. Evidence and approvals vary by jurisdiction.
Evidence

Evidence, limitations and clinical context

SAHPRA specifically identifies Semax and Selank among illegally marketed peptides in South Africa. Routine online sale is disabled.
Clinical access

Not available for routine online purchase

This treatment is not enabled for routine online sale. A doctor can discuss the evidence, suitability and lawful alternatives. Where an unregistered medicine is considered clinically necessary, any access must follow the applicable SAHPRA authorisation process before supply.

Clinical assessment Clinician authorisation